CLL patients exhibit increased concentrations of soluble CD8 (sCD8) and soluble IL-2R (sIL-2R), particularly those with aggressive leukemia, which are related to the disease stage and lymphocyte count [17]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.